{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:04:48Z","timestamp":1781787888843,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":950,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1093\/annonc\/mdx098","type":"journal-article","created":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T11:08:05Z","timestamp":1493118485000},"page":"1250-1259","source":"Crossref","is-referenced-by-count":53,"title":["Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma"],"prefix":"10.1016","volume":"28","author":[{"given":"H.R.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.N.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.S.","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.G.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.H.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-M.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-H.","family":"Pyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.Y.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.A.","family":"Youn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-J.","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Paik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.-M.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.C.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdx098_bb0010","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.3390\/cancers7030864","article-title":"The evolution of therapies in non-small cell lung cancer","volume":"7","author":"Boolell","year":"2015","journal-title":"Cancers (Basel)"},{"key":"10.1093\/annonc\/mdx098_bb0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40880-016-0135-x","article-title":"Epidemiology of lung cancer and approaches for its prediction: a systematic review and analysis","volume":"35","author":"Dubey","year":"2016","journal-title":"Chin J Cancer"},{"key":"10.1093\/annonc\/mdx098_bb0020","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1200\/JCO.2012.43.8622","article-title":"Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer","volume":"31","author":"Kim","year":"2013","journal-title":"JCO"},{"key":"10.1093\/annonc\/mdx098_bb0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cam4.357","article-title":"Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps","volume":"4","author":"Ilie","year":"2015","journal-title":"Cancer Med"},{"key":"10.1093\/annonc\/mdx098_bb0030","doi-asserted-by":"crossref","first-page":"62ra93","DOI":"10.1126\/scitranslmed.3001451","article-title":"Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer","volume":"2","author":"Weiss","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1093\/annonc\/mdx098_bb0035","doi-asserted-by":"crossref","first-page":"15049","DOI":"10.1038\/cddiscovery.2015.49","article-title":"FGFR1 inhibition in lung squamous cell carcinoma: questions and controversies","volume":"1","author":"Weeden","year":"2015","journal-title":"Cell Death Discov"},{"key":"10.1093\/annonc\/mdx098_bb0040","doi-asserted-by":"crossref","first-page":"8035","DOI":"10.1200\/jco.2014.32.15_suppl.8035","article-title":"A phase 1b open-label multicenter study of AZD4547 in patients with advanced squamous cell lung cancers: preliminary antitumor activity and pharmacodynamic data","volume":"32","author":"Paik","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdx098_bb0045","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1158\/1078-0432.CCR-13-3060","article-title":"FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies","volume":"20","author":"Wynes","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdx098_bb0050","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1158\/0008-5472.CAN-12-3342","article-title":"The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology","volume":"73","author":"Abaan","year":"2013","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdx098_bb0055","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrc1951","article-title":"The NCI60 human tumour cell line anticancer drug screen","volume":"6","author":"Shoemaker","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1093\/annonc\/mdx098_bb0060","first-page":"998","article-title":"Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer","volume":"4","author":"Hidalgo","year":"2014","journal-title":"Discov"},{"key":"10.1093\/annonc\/mdx098_bb0065","doi-asserted-by":"crossref","first-page":"e0142429","DOI":"10.1371\/journal.pone.0142429","article-title":"Application of a patient derived xenograft model for predicative study of uterine fibroid disease","volume":"10","author":"Fritsch","year":"2015","journal-title":"PLoS One"},{"key":"10.1093\/annonc\/mdx098_bb0070","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.1158\/0008-5472.CAN-14-0826","article-title":"Targeting the c-Met\/FZD8 signaling axis eliminates patient-derived cancer stem-like cells in head and neck squamous carcinomas","volume":"74","author":"Sun","year":"2014","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdx098_bb0075","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1158\/1078-0432.CCR-12-2694","article-title":"Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models","volume":"18","author":"Zhang","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdx098_bb0080","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res"},{"key":"10.1093\/annonc\/mdx098_bb0085","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10585-015-9734-1","article-title":"Cediranib combined with chemotherapy reduces tumor dissemination and prolongs the survival of mice bearing patient-derived ovarian cancer xenografts with different responsiveness to cisplatin","volume":"32","author":"Decio","year":"2015","journal-title":"Clin Exp Metastasis"},{"key":"10.1093\/annonc\/mdx098_bb0090","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm.3559","article-title":"Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine","volume":"20","author":"Van Allen","year":"2014","journal-title":"Nat Med"},{"key":"10.1093\/annonc\/mdx098_bb0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1158\/1541-7786.MCR-08-0021","article-title":"Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma","volume":"7","author":"Gartside","year":"2009","journal-title":"Mol Cancer Res"},{"key":"10.1093\/annonc\/mdx098_bb0100","doi-asserted-by":"crossref","first-page":"e1003749","DOI":"10.1371\/journal.pcbi.1003749","article-title":"Hotspot mutations in KIT receptor differentially modulate its allosterically coupled conformational dynamics: impact on activation and drug sensitivity","volume":"10","author":"Chauvot de Beauchene","year":"2014","journal-title":"PLoS Comput Biol"},{"key":"10.1093\/annonc\/mdx098_bb0105","doi-asserted-by":"crossref","first-page":"e20351","DOI":"10.1371\/journal.pone.0020351","article-title":"Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer","volume":"6","author":"Dutt","year":"2011","journal-title":"PLoS One"},{"key":"10.1093\/annonc\/mdx098_bb0110","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1002\/cncr.30135","article-title":"Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer with FGFR1 amplification: a single-arm, phase 2 study","volume":"122","author":"Lim","year":"2016","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdx098_bb0115","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ctrv.2015.04.011","article-title":"FGFR as potential target in the treatment of squamous non small cell lung cancer","volume":"41","author":"Tiseo","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"10.1093\/annonc\/mdx098_bb0120","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s40880-015-0028-4","article-title":"Predictive biomarkers in precision medicine and drug development against lung cancer","volume":"34","author":"Fang","year":"2015","journal-title":"Chin J Cancer"},{"key":"10.1093\/annonc\/mdx098_bb0125","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1126\/science.1254721","article-title":"Patient-derived models of acquired resistance can identify effective drug combinations for cancer","volume":"346","author":"Crystal","year":"2014","journal-title":"Science"},{"key":"10.1093\/annonc\/mdx098_bb0130","doi-asserted-by":"crossref","first-page":"e0134346","DOI":"10.1371\/journal.pone.0134346","article-title":"Development and characterization of bladder cancer patient-derived xenografts for molecularly guided targeted therapy","volume":"10","author":"Pan","year":"2015","journal-title":"PLoS One"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419324275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419324275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/28\/6\/1250\/17646342\/mdx098.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T08:25:38Z","timestamp":1624695938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419324275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0923753419324275"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdx098","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}